Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy
Clinical trial NCT00786383 · COMPLETED
Trial details
- NCT number
- NCT00786383
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2009-01-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.